Yıl: 2012 Cilt: 8 Sayı: 1 Sayfa Aralığı: 11 - 18 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı

Öz:
Amaç: Meme kanserli olgularda, hastalığın evresinin doğru saptanması ve geri ye tümör dokusunun bırakılmaması uygun tedavi planlamasında belirleyici roloynamaktadır. Meme manyetik rezonans görüntüleme (MRG), meme kanserliolgularda preoperatif cerrahi planlamasında kullanımı artan bir modalitedir. Buçalışmanın amacı, prospektif olarak, meme kanserli kadınlarda, cerrahi önce si elde edilen meme MRG’nin cerrahi tedavi planlamaya katkısını araştırmaktır.Hastalar ve Yöntem: Çalışmaya 30 hasta dahil edildi. Lezyonlar Breast ImagingReporting and Data System (BI-RADS) sınıflamasına göre 6 kategoride tanım landı. Veriler meme MRG incelemesi sonucu cerrahi planlamada yapılan değişik lik açısından analiz edildi. Bulgular: Hastaların primer tümör boyutları ile memeMRG ve histopatolojik değerlendirme ile ölçümlerinin yüksek düzeyde korelas yon gösterdiği saptandı (r:0.796, p:0.00). Meme MRG ile 11 hastada (%36) 14 eklezyon saptandı. İki hasta hariç tüm olgularda histopatolojik değerlendirme so nuçlarının MRG bulguları ile uyumluluk gösterdiği görüldü. Tüm hasta grubundameme MRG bulgularının cerrahi değişikliğe neden olduğu hasta oranı %17 idi.Mastektomi planlanan 16 olgunun 1’ine (%6.5) senkron kontrlateral meme kan seri nedeniyle ek meme koruyucu cerrahi (MKC) yapıldı. MKC planlanan olgula rın 4’ünde (%28) cerrahi plan mastektomi olarak değiştirildi. Hastaların 1’indeprimer kanserin sınırları ve uzanımları, meme MRG ile daha net ortaya kondu veMKC’den vazgeçilerek mastektomi uygulandı.Sonuç: Meme MRG bulgularının MKC planlanan hastalarda cerrahi planı de ğiştirebileceği klinik ve mamografik olarak saptanmış olup; preoperatif kont rastlı meme MRG’nin klinik ve mamografik saptanamayan okült invaziv ve no ninvaziv meme kanserlerinin yakalanmasında, tümör evrelemesinde, cerrahiplanlamada rol oynadığı düşünülmektedir.
Anahtar Kelime:

Konular: Tıbbi Araştırmalar Deneysel Onkoloji Radyoloji, Nükleer Tıp, Tıbbi Görüntüleme Cerrahi

The value of preoperative contrast-enhanced breast magnetic resonance imaging on surgical planning in breast cancer patients

Öz:
Objective: Accurate detection of tumor stage and no recurrent tumor af ter surgery play a determinant role in surgical planning in breast cancerpatients. Breast magnetic resonance imaging (MRI) is being increasinglyused in preoperative planning for breast cancer. The aim of this study is toevaluate the incremental value of preoperative breast MRI to surgical plan ning in women with diagnosis of breast cancer. Patients and methods: Thirtypatients were enrolled in this study. Lesions were categorized according tothe Breast Imaging Reporting and Data System (BI-RADS) classification. Thedata were analyzed according to the benefits and detriments of MRI findingsand changes in surgical planning made according to MRI results. Results:There was a high correlation between primary tumor size and breast MRI– histopathologic measurements (r:0.796, p:0.00). Fourteen additional lesionswere detected in 11 patients (%36) with MRI. MRI findings were concordantwith histopathologic results except in 2 patients. In 17% of total patientgroup, the surgical approach changed according to breast MRI findings. Anadditional breast- conserving surgery (BCS) was applied in 1 of 16 (%6.5)patients with synchroneus contrlateral breast cancer whom were planned toundergo mastectomy. In 4 patients (28%) with BCS decision, the surgical ap proach was changed to mastectomy. In one patient, the border and extansionof the primary cancer was detected more clearly by MRI and the decision ofBCS was changed to mastectomy.Conclusion: We found that MRI findings accurately guided the CBS planning.Preoperative contrast-enhanced breast MRI plays an important role in detec tion, staging and surgical planning in invasive and noninvasive cancers.
Anahtar Kelime:

Konular: Tıbbi Araştırmalar Deneysel Onkoloji Radyoloji, Nükleer Tıp, Tıbbi Görüntüleme Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1) Pain JA, Ebbs SR, Hern RP, Lowe S, Bradbeer JW. Assessment of breast cancer size: a comparison of methods. Eur J Surg Oncol 1992:18:44-48. (PMID: 1737593)
  • 2) Baker LH. Breast cancer detection demonstration project: five year summary report. CA Cancer J Clin 1982; 32:194-225. (PMID: 6805867)
  • 3) Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of tis, T1-2 breast carcinomas. Implications for clinical trials of breastconserving surgery. Cancer. 1985;56:979-90. (PMID: 2990668)
  • 4) Boetes C, Mus RD, Holland R, Barentsz JO, Strijk SP, Wobbes T, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995; 197:743-7. (PMID: 7480749)
  • 5) Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220:13-30. (PMID: 11425968)
  • 6) Hlawatsch A, Teifke A, Schmidt M, Thelen M. Preoperative assessment of breast cancer: sonography versus MR imaging. AJR Am J Roentgenol 2002;179:1493-501. (PMID: 12438043)
  • 7) Kristoffersen Wiberg M, Aspelin P, Sylvan M, Boné B. Comparison of lesion size estimated by dynamic MR imaging, mammography and histopathology in breast neoplasms. Eur Radiol 2003;13:1207-12. (PMID: 12764634)
  • 8) Osteen RT. Selection of patients for breast-conserving surgery. Cancer 1994;74:366-71. (PMID: 8004609)
  • 9) Davis PL, McCarty KS Jr. Magnetic resonance imaging in breast cancer staging. Top Magn Reson Imaging 1998;9:60 -75. (PMID: 9617902)
  • 10) Soderstrom CE, Harms SE, Copit DS, Ewans WP, Savino DA, Krakos PA, et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 1996;201:427-32. (PMID: 8888235)
  • 11) Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187:493-501. (PMID: 8475297)
  • 12) Mumtaz H, Hall-Craggs MA, Davidson T, Walmsley K, Thurell W, Kissin MW, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 1997;169:417-24. (PMID: 9242745)
  • 13) Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 1999; 17:110-119. (PMID: 10458224)
  • 14) Yang WT, Lam WW, Cheung H, Suen M, King WW, Metreweli C. Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer. J Ultrasound Med 1997;16:791 -7. (PMID: 9401992)
  • 15) Lee JM, Orel SG, Czerniecki BJ, Solin LJ, Schnall MD. MRI before reexcision surgery in patients with breast cancer. AJR Am J Roentgenol 2004;182:473-80. (PMID: 14736685)
  • 16) Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol 2002;20:3413-23. (PMID: 12177101)
  • 17) Friedrich M. MRI of the breast: state of the art. Eur Radiol 1998;8:707 -725. (PMID: 9601956)
  • 18) Harms SE. Breast magnetic resonance imaging. Semin Ultrasound CT MR 1998;19:104 -20. (PMID: 9503523)
  • 19) Heywang-Kobrunner SH, Oellinger H. Breast: Magnevist monograph. Oxford, England: Blackwell Scientific Publications, 1994. p.79-84.
  • 20) Rieber A, Merkle E, Böhm W, Brambs HJ, Tomczak R. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 1997; 21:773-9. (PMID: 9294574)
  • 21) Roubidoux MA, Lai NE, Paramagul C, Joynt LK, Helvie MA. Mammographic appearance of cancer in the opposite breast: comparison with the first cancer. AJR Am J Roentgenol 1996;166:29-31. (PMID: 8571898)
  • 22) Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 2000;88:2739-50. (PMID: 10870056)
  • 23) Liberman L, Morris EA, Kim CM, Kaplan JB, Abramson AF, Menell JH, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol. 2003;180:333-41. (PMID: 12540428)
  • 24) Lee SG, Orel SG, Woo IJ, Cruz-Jove E, Putt ME, Solin LJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 2003;226:773-8. (PMID: 12601182)
  • 25) Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, et al. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 2007; 243: 670-80. (PMID: 17446524)
  • 26) Orel SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994;190:485-93. (PMID: 8284404)
  • 27) Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:5-7. (PMID: 10189459)
  • 28) Bone B, Pentek Z, Perbeck L, Veress B. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol 1997;38:489-96. (PMID: 9240665)
  • 29) Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology. 1999;213:881-8. (PMID: 10580970)
  • 30) Sardanelli F, Podo F, D’Agnolo G, Verdecchia A, Santaquilani M, Musumeci R, et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT Study): interim results. Radiology 2007; 242: 698-715. (PMID: 17244718)
  • 31) Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 2007; 43: 1905-17. (PMID: 17681781)
  • 32) Bedrosian I, Mick R, Orel SG, Schnall M, Reynolds C, Spitz FR, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98:468-73. (PMID: 12879462)
  • 33) Fischer U, Zachariae O, Baum F, von Heyden D, Funke M, Liersch T. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol. 2004; 14:1725-31. (PMID: 15248080)
APA SEVER A, KAYHAN A, CİMŞİT Ç, KAYA H, Gulluoglu M, ARIBAL E (2012). Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı. , 11 - 18.
Chicago SEVER Ali,KAYHAN ARDA,CİMŞİT Çağatay,KAYA Handan,Gulluoglu Mahmut Bahadir,ARIBAL Erkin Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı. (2012): 11 - 18.
MLA SEVER Ali,KAYHAN ARDA,CİMŞİT Çağatay,KAYA Handan,Gulluoglu Mahmut Bahadir,ARIBAL Erkin Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı. , 2012, ss.11 - 18.
AMA SEVER A,KAYHAN A,CİMŞİT Ç,KAYA H,Gulluoglu M,ARIBAL E Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı. . 2012; 11 - 18.
Vancouver SEVER A,KAYHAN A,CİMŞİT Ç,KAYA H,Gulluoglu M,ARIBAL E Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı. . 2012; 11 - 18.
IEEE SEVER A,KAYHAN A,CİMŞİT Ç,KAYA H,Gulluoglu M,ARIBAL E "Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı." , ss.11 - 18, 2012.
ISNAD SEVER, Ali vd. "Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı". (2012), 11-18.
APA SEVER A, KAYHAN A, CİMŞİT Ç, KAYA H, Gulluoglu M, ARIBAL E (2012). Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı. Meme Sağlığı Dergisi, 8(1), 11 - 18.
Chicago SEVER Ali,KAYHAN ARDA,CİMŞİT Çağatay,KAYA Handan,Gulluoglu Mahmut Bahadir,ARIBAL Erkin Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı. Meme Sağlığı Dergisi 8, no.1 (2012): 11 - 18.
MLA SEVER Ali,KAYHAN ARDA,CİMŞİT Çağatay,KAYA Handan,Gulluoglu Mahmut Bahadir,ARIBAL Erkin Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı. Meme Sağlığı Dergisi, vol.8, no.1, 2012, ss.11 - 18.
AMA SEVER A,KAYHAN A,CİMŞİT Ç,KAYA H,Gulluoglu M,ARIBAL E Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı. Meme Sağlığı Dergisi. 2012; 8(1): 11 - 18.
Vancouver SEVER A,KAYHAN A,CİMŞİT Ç,KAYA H,Gulluoglu M,ARIBAL E Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı. Meme Sağlığı Dergisi. 2012; 8(1): 11 - 18.
IEEE SEVER A,KAYHAN A,CİMŞİT Ç,KAYA H,Gulluoglu M,ARIBAL E "Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı." Meme Sağlığı Dergisi, 8, ss.11 - 18, 2012.
ISNAD SEVER, Ali vd. "Meme kanserli olgularda operasyon öncesi dinamik kontrastlı meme manyetik rezonans görüntülemenin cerrahi planlamaya katkısı". Meme Sağlığı Dergisi 8/1 (2012), 11-18.